Login / Signup

Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus.

Fernanda C CardosoZoltan DekanJennifer J SmithJennifer R DeuisIrina VetterVolker HerzigPaul F AlewoodGlenn F KingRichard James Lewis
Published in: British journal of pharmacology (2017)
μ-TRTX-Df1a shows potential as a new molecule for the development of drugs to treat pain disorders mediated by voltage-gated ion channels.
Keyphrases
  • chronic pain
  • escherichia coli
  • pain management
  • neuropathic pain
  • human health
  • spinal cord injury
  • risk assessment
  • postoperative pain